InvestorsHub Logo
Followers 0
Posts 48
Boards Moderated 0
Alias Born 09/30/2017

Re: Milarepa post# 2903

Tuesday, 04/16/2019 11:30:19 AM

Tuesday, April 16, 2019 11:30:19 AM

Post# of 3104
As an example of the immense research going on into Nad+ precursors is Dr. Brunhilde Felding's work at Scripps Research in San Diego. They have discovered that by boosting Nad+ levels breast cancer metastasis can be halted:

https://www.scripps.edu/felding/images/FeldingLabStudiesHandout.pdf

https://www.scripps.edu/felding/research.html

Chromadex supplied the NR for this study and has licensed the pending parent from Scripps:

http://investors.chromadex.com/phoenix.zhtml?c=212121&p=irol-newsArticle&ID=2280200
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDXC News